Commenced site activation for REVEAL pivotal trial in accordance with previously aligned upon key design elements, following receipt of No Objection Letter (NOL) from Health Canada and feedback from ...

Commenced site activation for REVEAL pivotal trial in accordance with previously aligned upon key design elements, following ...

Completed dosing of FTD-GRN Cohort 2 in upliFT-D study Reported updated interim data showing that PBFT02 continued to demonstrate robust, d ...

This story was originally published by Barn Raiser, your independent source for rural and small town news. By Joel Bleifuss | ...

Now, new study shoes that cybercriminials are using these SVG images in fake Facebook posts to spread malware.

In August 2025, Hoffmann-La Roche announced a study is to compare the efficacy and safety of glofitamab in combination with ...

Screen time in childhood and adolescence is positively associated with higher cardiometabolic risk, supported by consistent ...